The effects of teriparatide on acceleration of bone healing following atypical femoral fracture: comparison between daily and weekly administration
- PMID: 30105400
- DOI: 10.1007/s00198-018-4658-7
The effects of teriparatide on acceleration of bone healing following atypical femoral fracture: comparison between daily and weekly administration
Abstract
We compared the effectiveness of promoting bone healing between two teriparatide preparations for atypical femoral fracture (AFF). A total of 45 AFFs were included in this study, and we compared the duration of bone union. Teriparatide administered by daily injection enhanced bone union more than weekly administration in complete AFFs.
Introduction: The efficacy of teriparatide for atypical femoral fracture (AFF) has been recently reported. Although two different teriparatide preparations can be used to treat osteoporosis in Japan, daily or weekly injection, all previous reports on the effectiveness of teriparatide for AFF only examined daily injection formulations. Therefore, we compared the promotion of bone healing between the two teriparatide preparations for AFF.
Methods: A total of 45 consecutive AFFs in 43 Japanese patients were included in this study. They received either a daily 20-μg teriparatide injection (daily group; n = 32) or a once-a-week 56.5-μg teriparatide injection (weekly group; n = 13). We compared the clinical background and duration of bone union between these two groups.
Results: When all patents were included, the fracture healing time was not significantly different between the two groups. Only patients with complete AFFs had significantly fewer daily bisphosphonate or denosumab injections than the weekly group (P < 0.05). The fracture healing time in the daily group (6.1 ± 4.1 months) was significantly shorter than that in the weekly group (10.1 ± 4.2 months) (P < 0.05). Even if the influence of bisphosphonate or denosumab usage was excluded, a similar significant difference was observed in the fracture healing time (P < 0.05). There was no significant difference between the two groups among patients with incomplete AFFs.
Conclusions: Daily teriparatide injections enhance bone union more than weekly injections in complete AFF patients.
Keywords: Atypical femoral fracture; Daily; Teriparatide; Weekly.
Similar articles
-
Healing of bisphosphonate-associated atypical femoral fractures in patients with osteoporosis: a comparison between treatment with and without teriparatide.J Bone Miner Metab. 2015 Sep;33(5):553-9. doi: 10.1007/s00774-014-0617-3. Epub 2014 Sep 17. J Bone Miner Metab. 2015. PMID: 25227287
-
Different surgical outcomes in a patient with bilateral atypical femoral fracture related to bisphosphonate use with or without teriparatide treatment.Osteoporos Int. 2019 Nov;30(11):2349-2354. doi: 10.1007/s00198-019-05131-2. Epub 2019 Aug 19. Osteoporos Int. 2019. PMID: 31428823
-
A retrospective bicenter comparative study of surgical outcomes of atypical femoral fracture: Potential effect of teriparatide on fracture healing and callus formation.Bone. 2019 Nov;128:115033. doi: 10.1016/j.bone.2019.08.006. Epub 2019 Aug 6. Bone. 2019. PMID: 31398503
-
Medical Management of Patients After Atypical Femur Fractures: a Systematic Review and Recommendations From the European Calcified Tissue Society.J Clin Endocrinol Metab. 2020 May 1;105(5):1682-99. doi: 10.1210/clinem/dgz295. J Clin Endocrinol Metab. 2020. PMID: 31867670 Free PMC article.
-
Current Understanding of Epidemiology, Pathophysiology, and Management of Atypical Femur Fractures.Curr Osteoporos Rep. 2018 Aug;16(4):519-529. doi: 10.1007/s11914-018-0464-6. Curr Osteoporos Rep. 2018. PMID: 29951870 Free PMC article. Review.
Cited by
-
Treatment of postmenopausal osteoporosis with recombinant human parathyroid hormone and electromagnetic field.Aging Clin Exp Res. 2025 Feb 22;37(1):44. doi: 10.1007/s40520-025-02932-w. Aging Clin Exp Res. 2025. PMID: 39985668 Free PMC article. Clinical Trial.
-
Does Teriparatide Improve Fracture Union?: A Systematic Review.J Bone Metab. 2020 Aug;27(3):167-174. doi: 10.11005/jbm.2020.27.3.167. Epub 2020 Aug 31. J Bone Metab. 2020. PMID: 32911581 Free PMC article.
-
Intermittent Parathyroid Hormone Accelerates Stress Fracture Healing More Effectively Following Cessation of Bisphosphonate Treatment.JBMR Plus. 2020 Aug 6;4(9):e10387. doi: 10.1002/jbm4.10387. eCollection 2020 Sep. JBMR Plus. 2020. PMID: 32995690 Free PMC article.
-
A comparative effectiveness pilot study of teriparatide for medication-related osteonecrosis of the jaw: daily versus weekly administration.Osteoporos Int. 2020 Mar;31(3):577-585. doi: 10.1007/s00198-019-05199-w. Epub 2019 Nov 25. Osteoporos Int. 2020. PMID: 31768589
-
Use of Teriparatide in preventing delayed bone healing and nonunion: a multicentric study on a series of 20 patients.BMC Musculoskelet Disord. 2023 Mar 11;24(1):184. doi: 10.1186/s12891-023-06278-0. BMC Musculoskelet Disord. 2023. PMID: 36906529 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical